Dr. med.
Alina Jander
  • Assistant physician
Working area

Contact

Location

Main Building O10 , 2nd Floor
Languages
German (Mother tongue)
English

Publications

2026

Effect of subcutaneous foslevodopa/foscarbidopa therapy on non-motor symptoms in advanced PD patients
Jander A, Bergner S, Schönwald B, Pötter-Nerger M, Buhmann C, Hidding U
J NEUROL. 2026;273(7):.

Hyperacute Interleukin-1β Production and Neutrophil Extracellular Trap Formation in the Cerebral Circulation of Stroke Patients with Large Vessel Occlusion
Münsterberg J, Brekenfeld C, Englert H, Piepke M, Dress R, Oertel M, Fischer T, Hackbusch R, Zha M, Cai H, Casar C, Schädlich I, Winter L, Jander A, Degenhardt K, Bester M, Flottmann F, Hanning U, Holst B, Worthman A, Hiefner J, Rutz B, Schlemm E, Thomalla G, Clausen B, Stowe A, Prinz I, Arumugam T, Glatzel M, Renné T, Fiehler J, Tolosa E, Magnus T, Gelderblom M
ANN NEUROL. 2026 [Epub ahead of print].

Single-cell omics and flow cytometry identify distinct immune states of dural and brain-infiltrating IL-17-producing γδ T cells after experimental stroke
Zha M, Jander A, Cai H, Piepke M, Degenhardt K, Winter L, Magnus T, Gelderblom M
J NEUROINFLAMM. 2026;23(1):.

2025

Subcutaneous foslevodopa/foscarbidopa initiation in a Parkinson's day-clinic - a suitable setting to ensure treatment efficacy, tolerability and psychosocial adaption
Jander A, Bergner S, Schönwald B, Pötter-Nerger M, Buhmann C, Hidding U
FRONT AGING NEUROSCI. 2025;17:.

2024

IL-17A-producing γδ T cells: A novel target in stroke immunotherapy
Piepke M, Jander A, Gagliani N, Gelderblom M
EUR J IMMUNOL. 2024;54(12):e2451067.

2022

Interleukin-1 Mediates Ischemic Brain Injury via Induction of IL-17A in γδ T Cells and CXCL1 in Astrocytes
Schädlich I, Vienhues J, Jander A, Piepke M, Magnus T, Lambertsen K, Clausen B, Gelderblom M
NEUROMOL MED. 2022;24(4):437-451.

2021

Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response
Piepke M, Clausen B, Ludewig P, Vienhues J, Bedke T, Javidi E, Rissiek B, Jank L, Brockmann L, Sandrock I, Degenhardt K, Jander A, Roth V, Schädlich I, Prinz I, Flavell R, Kobayashi Y, Renné T, Gerloff C, Huber S, Magnus T, Gelderblom M
J NEUROINFLAMM. 2021;18(1):.

Letzte Aktualisierung aus dem FIS: 11.07.2026 - 05:09 Uhr